FormDSignal
50

KAZIA THERAPEUTICS LTD raises $2.1M under Reg D

Company raise · Closed · Sydney, Alberta · Form D filed 2025-01-17
First raise on EDGARPlacement agent engaged

How this compares

  • No earlier fund launch by this sponsor appears on EDGAR.

Computed from every Form D fund launch on EDGAR since late 2024, not sampled. Amounts are the stated offering size; indefinite offerings are excluded.

Kazia Therapeutics on EDGAR

Earlier and related filings by the same issuer and sponsor.

People on the filing

Steven CoffeyDirector
John FriendExecutive Officer, Director
Jeffrey BonacordaExecutive Officer
Robert AppleDirector
Ebru DavidsonDirector
Bryce CarmineDirector
Elissa HansenExecutive Officer

Signed by John Friend, Chief Executive Officer.

Placement agents / sales compensation: Maxim Group LLC

Why now — by persona

Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO.

Filing contact

The issuer's phone number and address from the filing are shown to subscribers. See plans.